DiscoverJACC Specialty JournalsJACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients

JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Update: 2024-09-11
Share

Description

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, Yen-Wen Liu, MD, PhD, Professor of Medicine, FESC and Yu-Ling Hsu, MD discuss the study design, findings and potential implications for clinical practice and future research questions for the prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients

JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients